no image available Dickens & Co. "Evaluating the Cost-Benefit Analysis of Adjuvant Therapy for Colon Cancer: A Comparative Analysis of XELOX and FOLFOX4" "Uncovering the Financial Implications of Adjuvant Chemotherapy Options for Colon Cancer Patients" Price: 26.00€